Organization · Grant Maker

Technology & Commericalization Board, Republic of Kazakhstan

The Technology & Commercialization Board, also known as Innovative Ventures, is a government body in Kazakhstan focused on supporting underserved entrepreneurs through investment and fund management. It operates internationally, providing various forms of capital and commercialization support.

Grant MakerFunderGrantor

Overview

What Technology & Commericalization Board, Republic of Kazakhstan does

What Technology & Commericalization Board, Republic of Kazakhstan is

The Technology & Commercialization Board, also known as Innovative Ventures, is a government body in Kazakhstan focused on supporting underserved entrepreneurs through investment and fund management. It operates internationally, providing various forms of capital and commercialization support.

How it participates in the startup ecosystem

The current public profile supports funder and grantor capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.

Operational profile

Organization status and context

Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.

Operational status
Active
Organization type
Grant Maker
Founded
Founded in 1986
Approximate age
About 40 years
Structured capabilities
Funder · Grantor
Last reviewed
March 26, 2026

Official channels

Find Technology & Commericalization Board, Republic of Kazakhstan elsewhere

Open the official website or a supported primary organization account.

Capability profile

Technology & Commericalization Board, Republic of Kazakhstan as a funder

Investment thesis

The Technology & Commercialization Board, also known as Innovative Ventures, focuses on supporting underserved and under-financed entrepreneurs through investment and fund management for emerging companies across various regions.

Focus narrative

Innovative Ventures invests across various stages of company development, from innovation grants to Series D funding. Their investment amounts range from $100,000 to $10 million, emphasizing the importance of aligning capital types with the specific growth stages and risks of the companies they support. They also provide assistance in international expansion, helping companies manage cultural, legal, and political challenges.

Value beyond capital

Innovative Ventures adds value by providing not only financial support but also strategic guidance for international expansion, helping portfolio companies navigate various risks associated with entering new markets.

Terms and economics

Typical check
$100,000–$10,000,000

Focus and fit

Stages
Friends and Family · Angel · Accelerator · Pre-seed · Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Series D
Regions
Europe · Global · North America · Sub Saharan Africa

Availability

Currently deploying
Not published

Portfolio and track record

Recorded notable exits
Neogen Corp.

Portfolio context

Innovative Ventures has a diverse portfolio that includes notable companies such as Neogen Corp., a leader in food safety with a $3.2 billion exit; Applied Intelligence Systems Inc., acquired by ESI; and Personal Bibliographic Systems Inc., acquired by Thompson Financial. Other portfolio companies include Flexoprint, a printing business in Russia, and MRCI, a global seafood processing company.

Capability profile

Technology & Commericalization Board, Republic of Kazakhstan as a grantor

Grant thesis

The Technology & Commercialization Board, also known as Innovative Ventures, aims to support underserved and under-financed entrepreneurs across various regions by providing investment and fund management services.

Focus narrative

Innovative Ventures invests in a range of sectors, providing services that include venture capital, growth capital, and commercialization support. Their investment strategy encompasses various stages of company development, from innovation grants to Series D funding, with investment amounts ranging from $100,000 to $10 million. The organization emphasizes the importance of matching the type of capital to the specific growth stage and risks of the companies they support.

Value and support

Beyond funding, Innovative Ventures offers commercialization support and advisory services to help companies expand internationally and manage risks effectively.

Grant economics

Grant range
$100,000–$10,000,000
Dilutive
No
Nonprofit only
No

Eligibility and fit

Stages
Friends and Family · Angel · Accelerator · Pre-seed · Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Series D
Audience
Founders
Regions
Europe · Global · North America · Sub Saharan Africa

Process and recipient context

Application process

Innovative Ventures assists companies in navigating cultural, legal, and political risks associated with international expansion. They provide tailored support to ensure that entrepreneurs receive the right type of capital for their growth stage.

Recipient context

Notable past grantees include Neogen Corp., a leader in food safety with a $3.2 billion exit value; Applied Intelligence Systems Inc., specializing in machine vision technology; and Personal Bibliographic Systems Inc., focusing on bibliographic software.

Common questions

What to know about Technology & Commericalization Board, Republic of Kazakhstan

Upseed classifies Technology & Commericalization Board, Republic of Kazakhstan under the Grant Maker organization type. Its current public profile includes funder and grantor capabilities.

Next step

Keep comparing startup organizations

Return to the organization index or continue through a verified sector, place, peer, or program connected to this profile.

Source and update disclosure

Know what this page is based on

Source basis

Public organization and program material, official websites, and structured Upseed records.

Last reviewed

March 26, 2026

Known limits

Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.

Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.